Quoin Pharmaceuticals Ltd Stock Today
| QNRX Stock | USD 0.30 0.01 3.45% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Quoin Pharmaceuticals is trading at 0.3 as of the 23rd of March 2025; that is 3.45 percent increase since the beginning of the trading day. The stock's open price was 0.29. Quoin Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 29th of July 2016 | Category Healthcare | Classification Health Care |
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Quoin Pharmaceuticals, Ltd. was incorporated in 2018 and is based in Ashburn, Virginia. The company has 20.59 M outstanding shares of which 44.39 K shares are at this time shorted by private and institutional investors with about 0.26 trading days to cover. More on Quoin Pharmaceuticals Ltd
Moving together with Quoin Stock
Moving against Quoin Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Quoin Stock Highlights
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsQuoin Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Quoin Pharmaceuticals' financial leverage. It provides some insight into what part of Quoin Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quoin Pharmaceuticals Ltd (QNRX) is traded on NASDAQ Exchange in USA. It is located in 42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349 and employs 3 people. Quoin Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.18 M. Quoin Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 20.59 M outstanding shares of which 44.39 K shares are at this time shorted by private and institutional investors with about 0.26 trading days to cover.
Quoin Pharmaceuticals Ltd currently holds about 2.69 M in cash with (7.86 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Quoin Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationQuoin Pharmaceuticals owns a total of 20.59 Million outstanding shares. Quoin Pharmaceuticals holds 6.59 pct. of its outstanding shares held by insiders and 7.51 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Quoin Ownership Details
Quoin Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Ubs Group Ag | 2024-12-31 | 4.8 K | |
| Sbi Securities Co Ltd | 2024-12-31 | 24.0 | |
| Raiffeisen Bank International Ag | 2024-12-31 | 17.0 | |
| Resources Investment Advisors Inc | 2024-09-30 | 0.0 | |
| Susquehanna International Group, Llp | 1224-09-30 | 0.0 | |
| Jpmorgan Chase & Co | 2024-12-31 | 0.0 | |
| Two Sigma Investments Llc | 2024-09-30 | 0.0 | |
| Virtu Financial Llc | 2024-12-31 | 0.0 | |
| Bank Of America Corp | 2024-09-30 | 0.0 | |
| Armistice Capital, Llc | 2024-12-31 | 530 K | |
| Altium Capital Management, Lp | 2024-12-31 | 282.2 K |
Quoin Pharmaceuticals Historical Income Statement
Quoin Stock Against Markets
Additional Tools for Quoin Stock Analysis
When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.